Browse Results

  • Principal Investigator: Alencar, Alvaro

There are 3 clinical trial(s) matching your criteria.


CA209436:A Phase I/ II Study to Evaluate the Safety and Preliminary Efficacy of Nivolumab in Combination with Brentuximab Vedotin in Subjects with Relapsed Refractory Non Hodgkin Lymphomas with CD30 Expression CheckMate 436: CHECKpoint pathway and nivolumab clinical Trial Evaluation

Investigator: Alvaro Alencar

Institutional Protocol #: 20170179

National Clinical Trials Identifier: NCT02581631

Division: Cancer Center

Therapeutic Area: Leukemia, Lymphoma, and Myeloma

Phase: Phase I/II

Enrolling Since: 8/18/2017